Is BVNKF or VYM a better dividend investment in 2026?

BVNKF currently yields 6.73% with a 5% 5-year dividend growth rate. VYM yields 2.41% with 7.8% growth. The better choice depends on your goal: BVNKF offers higher current income.

What is the dividend yield difference between BVNKF and VYM?

BVNKF has a forward dividend yield of 6.73% ($2.00/share annually). VYM yields 2.41% ($3.51/share annually). The yield gap is 4.32 percentage points.

Home › Compare › BVNKF vs VYM

BVNKF vs VYM: Dividend Comparison 2026

BVNKF yields 6.73% · VYM yields 2.41%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 BVNKF wins by $3.4K in total portfolio value

INVESTMENT

TIME HORIZON10 years

BVNKF

● Live price

6.73%

Share price

$29.71

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$31.2K

Annual income

$1,032.71

Full BVNKF calculator →

VYM

Vanguard High Dividend Yield ETF

● Live price

2.41%

Share price

$145.48

Annual div

$3.51

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$27.8K

Annual income

$278.55

Full VYM calculator →

Portfolio growth — BVNKF vs VYM

📍 BVNKF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	BVNKF	VYM
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, BVNKF + VYM cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

BVNKF pays

VYM pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BVNKF

Annual income on $10K today (after 15% tax)

$572.20/yr

After 10yr DRIP, annual income (after tax)

$877.80/yr

VYM

Annual income on $10K today (after 15% tax)

$205.23/yr

After 10yr DRIP, annual income (after tax)

$236.77/yr

At 15% tax rate, BVNKF beats the other by $641.04/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BVNKF + VYM for your $10,000?

BVNKF: 50%VYM: 50%

100% VYM50/50100% BVNKF

Portfolio after 10yr

$29.5K

Annual income

$655.63/yr

Blended yield

2.22%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BVNKF buys

VYM buys

No recent congressional trades found for BVNKF or VYM in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricBVNKFVYM

Forward yield	6.73% ✓	2.41%
Annual dividend / share	$2.00	$3.51 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$31.2K ✓	$27.8K
Annual income after 10y	$1,032.71 ✓	$278.55
Total dividends collected	$8.6K ✓	$2.6K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: BVNKF vs VYM ($10,000, DRIP)

Year	BVNKF Portfolio	BVNKF Income/yr	VYM Portfolio	VYM Income/yr	Gap
1← crossover	$11,373	$673.17	$11,151	$241.44	+$222.00 → BVNKF
2	$12,885	$715.53	$12,413	$246.79	+$472.00 → BVNKF
3	$14,544	$757.60	$13,794	$251.79	+$750.00 → BVNKF
4	$16,362	$799.23	$15,306	$256.47	+$1.1K → BVNKF
5	$18,347	$840.27	$16,960	$260.84	+$1.4K → BVNKF
6	$20,512	$880.60	$18,768	$264.92	+$1.7K → BVNKF
7	$22,868	$920.10	$20,745	$268.71	+$2.1K → BVNKF
8	$25,428	$958.68	$22,905	$272.24	+$2.5K → BVNKF
9	$28,204	$996.24	$25,265	$275.51	+$2.9K → BVNKF
10	$31,211	$1,032.71	$27,842	$278.55	+$3.4K → BVNKF

BVNKF vs VYM: Complete Analysis 2026

BVNKF — Stock

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name. It is also developing MVA-BN (freeze-dried) that has completed Phase III clinical trials for the treatment of smallpox; MVA-BN RSV, which is in Phase III clinical trials for the treatment of respiratory syncytial virus; ABNCoV2 that has completed Phase II clinical trial for the treatment of SARS-CoV-2; and TAEK-VAC, which is in Phase I/II clinical trial for treatment of advanced HER2 and brachyury-expressing cancers. It has license and collaboration agreement with AdaptVac; and license agreements with National Cancer Institute and Public Health Service. The company operates in the United States, Belgium, Germany, the Netherlands, Sweden, Switzerland, Austria, the United Kingdom, Japan, and internationally. Bavarian Nordic A/S was incorporated in 1992 and is headquartered in Hellerup, Denmark.

Full BVNKF Calculator →

VYM — ETF

Seeks to track the performance of the FTSE High Dividend Yield Index, which measures the investment return of common stocks of companies characterized by high dividend yields. Provides a convenient way to track the performance of stocks that are forecasted to have above-average dividend yields. Follows a passively managed, full-replication approach.

Full VYM Calculator →

📬

Get this BVNKF vs VYM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BVNKF vs SCHD BVNKF vs JEPI BVNKF vs O BVNKF vs KO BVNKF vs MAIN BVNKF vs VIG BVNKF vs DGRO BVNKF vs HDV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.